OSCR
Overvalued by 225.4% based on the discounted cash flow analysis.
Market cap | $3.75 Billion |
---|---|
Enterprise Value | $2.52 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.11 |
Beta | 1.75 |
Outstanding Shares | 248,210,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 166.99 |
---|---|
PEG | -1011 |
Price to Sales | 0.51 |
Price to Book Ratio | 4.23 |
Enterprise Value to Revenue | 0.31 |
Enterprise Value to EBIT | -10.98 |
Enterprise Value to Net Income | 87 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 0.3 |
No data
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...